MOVENTIG 12.5 mg, film-coated tablet 30 tablets, CIP 3400930130254
Active ingredients: Naloxegol, Naloxegol oxalate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400930130254orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MOVENTIG 12,5 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 30 plaquette(s) aluminium de 1 comprimé(s)
- Marketing authorisation holder
- GRUNENTHAL
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Jul 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62119972CIP73013025CIP133400930130254Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| OXALATE DE NALOXÉGOLcomprimé | 14,2 mg · un comprimé | SA |
| NALOXÉGOLcomprimé | 12,5 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.